We can’t show the full text here under this license.
Abstract
A 59-year-old man developed acute pancreatitis after 2.5 years of weekly semaglutide therapy.
- The patient had multiple underlying conditions, including type 2 diabetes and stage IIIA colon cancer.
- Symptoms included epigastric pain and elevated lipase levels.
- Abdominal ultrasound indicated mild pancreatic parenchymal heterogeneity but no fluid collection.
- The patient improved with conservative management after discontinuing semaglutide.
- No recurrence of symptoms was noted during three months of follow-up.
- The case suggests a potential risk of pancreatitis associated with semaglutide in patients with multimorbidity.
Simplified